Clinical trials
Phase 2 Myelodysplastic Syndromes trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 2 |
| Completed | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cellphire Therapeutics, Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Haukeland University Hospital | 1 |
| Nordic MDS Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 4 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Hematologic Neoplasms | 1 |
| Hemochromatosis | 1 |
| Iron Overload | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Myeloproliferative Disorders | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.